Haibiao Xie

1.4k total citations
30 papers, 904 citations indexed

About

Haibiao Xie is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Haibiao Xie has authored 30 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Haibiao Xie's work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (10 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Haibiao Xie is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (10 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Haibiao Xie collaborates with scholars based in China and United States. Haibiao Xie's co-authors include Kan Gong, Kaifang Ma, Jingcheng Zhou, Kenan Zhang, Yuchen Liu, Weiren Huang, Jianfa Li, Wuping Yang, Yanqing Gong and Lin Cai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular Cell and Cancer Letters.

In The Last Decade

Haibiao Xie

30 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haibiao Xie China 15 723 504 148 110 68 30 904
Kaifang Ma China 11 432 0.6× 323 0.6× 150 1.0× 87 0.8× 35 0.5× 28 614
Hao Zheng China 19 730 1.0× 605 1.2× 80 0.5× 83 0.8× 78 1.1× 47 1.0k
Song Zhao China 16 459 0.6× 216 0.4× 119 0.8× 143 1.3× 96 1.4× 31 734
Jiang Shi China 14 619 0.9× 446 0.9× 69 0.5× 75 0.7× 50 0.7× 25 753
Guo-Sheng Hu China 14 613 0.8× 345 0.7× 72 0.5× 124 1.1× 71 1.0× 38 824
Haiyun Xie China 20 953 1.3× 575 1.1× 101 0.7× 97 0.9× 37 0.5× 31 1.1k
Jianning Zhai Hong Kong 10 818 1.1× 435 0.9× 71 0.5× 211 1.9× 145 2.1× 15 1.0k
Arabella Wan China 10 1.1k 1.5× 632 1.3× 84 0.6× 133 1.2× 59 0.9× 18 1.2k

Countries citing papers authored by Haibiao Xie

Since Specialization
Citations

This map shows the geographic impact of Haibiao Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibiao Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibiao Xie more than expected).

Fields of papers citing papers by Haibiao Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haibiao Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibiao Xie. The network helps show where Haibiao Xie may publish in the future.

Co-authorship network of co-authors of Haibiao Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Haibiao Xie. A scholar is included among the top collaborators of Haibiao Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haibiao Xie. Haibiao Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Jiayi, et al.. (2025). Adeno-associated virus mediated artificial circular RNA for triggering cancer immunotherapy to treat prostate cancer. Frontiers in Oncology. 15. 1443571–1443571. 1 indexed citations
2.
3.
Xu, Yawei, Jingcheng Zhou, Lei Li, et al.. (2022). FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability. International Journal of Biological Sciences. 18(15). 5943–5962. 60 indexed citations
4.
Xie, Haibiao, Kaifang Ma, Kenan Zhang, et al.. (2021). Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway. Cell Death and Disease. 12(1). 1–1. 123 indexed citations
5.
Xu, Yawei, Lei Li, Wuping Yang, et al.. (2021). Association between vasectomy and risk of prostate cancer: a meta-analysis. Prostate Cancer and Prostatic Diseases. 24(4). 962–975. 4 indexed citations
6.
Zhang, Kenan, Wuping Yang, Kaifang Ma, et al.. (2021). Clinical characteristics and risk factors for survival in affected offspring of von Hippel-Lindau disease patients. Journal of Medical Genetics. 59(10). 951–956. 5 indexed citations
7.
Xie, Haibiao, Kaifang Ma, Baoan Hong, et al.. (2020). Novel genetic characterisation and phenotype correlation in von Hippel-Lindau (VHL) disease based on the Elongin C binding site: a large retrospective study. Journal of Medical Genetics. 57(11). 744–751. 5 indexed citations
8.
Liu, Xijuan, Jeremy M. Simon, Haibiao Xie, et al.. (2020). Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss. Molecular Cell. 77(6). 1294–1306.e5. 45 indexed citations
9.
Hu, Lianxin, Haibiao Xie, Xijuan Liu, et al.. (2019). TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss. Cancer Discovery. 10(3). 460–475. 72 indexed citations
10.
Zhou, Jingcheng, Jiangyi Wang, Baoan Hong, et al.. (2019). Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma – a retrospective study using TCGA database. Aging. 11(6). 1633–1647. 130 indexed citations
11.
Ma, Kaifang, Baoan Hong, Jingcheng Zhou, et al.. (2019). The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel–Lindau Disease: A Retrospective Study of 32 Patients. Frontiers in Oncology. 9. 1122–1122. 10 indexed citations
12.
Hong, Baoan, Jingcheng Zhou, Kaifang Ma, et al.. (2019). TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway. International Journal of Biological Sciences. 15(3). 587–597. 57 indexed citations
13.
Ding, Mengting, Yuhan Liu, Yuhan Liu, et al.. (2018). Oestrogen promotes tumorigenesis of bladder cancer by inducing the enhancer RNA—eGREB1. Journal of Cellular and Molecular Medicine. 22(12). 5919–5927. 13 indexed citations
14.
Xie, Haibiao, Hengji Zhan, Qunjun Gao, et al.. (2018). Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cells. Cancer Letters. 422. 94–106. 9 indexed citations
15.
Xie, Haibiao, Bo Ma, Qunjun Gao, et al.. (2018). Long non-coding RNA CRNDE in cancer prognosis: Review and meta-analysis. Clinica Chimica Acta. 485. 262–271. 40 indexed citations
16.
Gao, Qunjun, Yuhan Liu, Haibiao Xie, et al.. (2018). Lentivirus-mediated shRNA targeting <em>MUTYH</em> inhibits malignant phenotypes of bladder cancer SW780 cells. OncoTargets and Therapy. Volume 11. 6101–6109. 7 indexed citations
17.
Gao, Qunjun, Haibiao Xie, Hengji Zhan, et al.. (2017). Prognostic Values of Long Noncoding RNA GAS5 in Various Carcinomas: An Updated Systematic Review and Meta-Analysis. Frontiers in Physiology. 8. 814–814. 22 indexed citations
18.
Xie, Haibiao, Xinhui Liao, Zhicong Chen, et al.. (2017). LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells. Journal of Cancer. 8(18). 3803–3811. 83 indexed citations
19.
Chen, Zhicong, Haibiao Xie, Yucheng Zhong, Yuchen Liu, & Weiren Huang. (2017). Role of nuclear paraspeckle assembly transcript 1 as a common molecular marker for prognosis in various cancers. Minerva Medica. 108(5). 2 indexed citations
20.
Xie, Haibiao, et al.. (2017). Colon cancer associated transcripts in human cancers. Biomedicine & Pharmacotherapy. 94. 531–540. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaifang Ma Breakdown of academic impact, for papers by Hao Zheng Breakdown of academic impact, for papers by Song Zhao Breakdown of academic impact, for papers by Jiang Shi Breakdown of academic impact, for papers by Guo-Sheng Hu Breakdown of academic impact, for papers by Haiyun Xie Breakdown of academic impact, for papers by Jianning Zhai Breakdown of academic impact, for papers by Arabella Wan
Rankless by CCL
2026